Cargando…

SARS-CoV-2 infections in 165 countries over time

Background: Understanding the dynamics of the COVID-19 pandemic and evaluating the efficacy of control measures requires knowledge of the number of infections over time. This number, however, often differs from the number of confirmed cases because of a large fraction of asymptomatic infections and...

Descripción completa

Detalles Bibliográficos
Autor principal:	Louca, Stilianos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413603/ https://www.ncbi.nlm.nih.gov/pubmed/34487852 http://dx.doi.org/10.1016/j.ijid.2021.08.067

Ejemplares similares

Are symptoms associated with SARS-CoV-2 infections evolving over time?
por: Ricco, M., et al.
Publicado: (2022)

Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time
por: Gentles, Lauren E., et al.
Publicado: (2022)

Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
por: Havervall, Sebastian, et al.
Publicado: (2022)

Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada
por: Udell, Jacob A., et al.
Publicado: (2022)

SARS-CoV-2 detection, viral load and infectivity over the course of an infection
por: Walsh, Kieran A., et al.
Publicado: (2020)

Telehealth in the times of SARS-CoV-2 infection for the otolaryngologist
por: Huang, Victoria W., et al.
Publicado: (2020)

When is the SARS-CoV-2 infection over and what is post-COVID?
por: Finsterer, Josef
Publicado: (2022)

Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
por: Borena, Wegene, et al.
Publicado: (2021)

Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions
por: Ali, Sheikh Taslim, et al.
Publicado: (2020)

Numerical simulation of the force of infection and the typical times of SARS-CoV-2 disease for different location countries
por: Al-Raeei, Marwan
Publicado: (2021)

Specific T-Cell Immune Response to SARS-CoV-2 Spike Protein over Time in Naïve and SARS-CoV-2 Previously Infected Subjects Vaccinated with BTN162b2
por: Vega-Magaña, Natali, et al.
Publicado: (2022)

SARS-CoV-2 and aerosols—Arguing over the evidence
por: Tang, Julian W.
Publicado: (2021)

Destruction mechanisms of ozone over SARS-CoV-2
por: Ataei-Pirkooh, Angila, et al.
Publicado: (2021)

Effects of the vaccination against SARS-CoV-2 on infections and on hospitalizations in European countries
por: Greiner, Alfred, et al.
Publicado: (2023)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections
por: Sajini, Abdulrahim A., et al.
Publicado: (2021)

SARS-CoV-2 in wastewater: Challenges for developing countries
por: Pandey, Deepshikha, et al.
Publicado: (2021)

Divergent humoral responses in mild to moderate SARS-CoV-2 infection over time – indication of persistence of the virus?
por: Bürgi, Justus J., et al.
Publicado: (2022)

Significant Correlations of SARS-CoV-2 Infection With Prevalence of Overweight/Obesity and Mean Body Mass Index in the SARS-CoV-2 Endemic Countries
por: Yanai, Hidekatsu
Publicado: (2020)

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
por: Merli, Michele, et al.
Publicado: (2020)

SARS-CoV-2 Infection among School Population of One Developing Country. Do School Closures Protect Students and Teachers against SARS-CoV-2 Infection?
por: Colonia, Carol Bibiana, et al.
Publicado: (2021)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection
por: Inaba, Masato, et al.
Publicado: (2021)

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
por: Mizrahi, Barak, et al.
Publicado: (2021)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022)

Intussusception and SARS-CoV-2 infection
por: Mercado-Martínez, Israel, et al.
Publicado: (2021)

Canine SARS-CoV-2 infection
por: Sit, Thomas HC, et al.
Publicado: (2020)

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
por: Lv, Huibin, et al.
Publicado: (2020)

The Immunopathobiology of SARS-CoV-2 Infection
por: Patel, Milankumar, et al.
Publicado: (2021)

Influenza vaccination in the time of SARS-CoV-2()
por: Reina, Jordi
Publicado: (2021)

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline
por: Bugatti, Serena, et al.
Publicado: (2020)

Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

Are Countries Becoming Better at SARS-CoV-2 Genomic Surveillance?
por: Mahanta, Utkarsha, et al.
Publicado: (2022)

Transmission Cycle of SARS-CoV and SARS-CoV-2
por: Yadav, Tushar, et al.
Publicado: (2020)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England
por: Eales, Oliver, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1gci309t6biva33655079dc5u8